PFIZER INC Cash Provided by (Used in) Operating Activities, Discontinued Operations
PFIZER INC (PFE) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2024-02-22
- PFIZER INC cash provided by (used in) operating activities, discontinued operations for the quarter ending 2022-12-31 was $0.00.
- PFIZER INC cash provided by (used in) operating activities, discontinued operations for the quarter ending 2022-10-02 was $5.00M.
- PFIZER INC cash provided by (used in) operating activities, discontinued operations for the quarter ending 2022-07-03 was -$5.00M, a 129.41% decline year-over-year.
- PFIZER INC cash provided by (used in) operating activities, discontinued operations for the quarter ending 2022-04-03 was $0.00.
- PFIZER INC cash provided by (used in) operating activities, discontinued operations for fiscal 2023 was $0.00.
- PFIZER INC cash provided by (used in) operating activities, discontinued operations for fiscal 2022 was $0.00.
- PFIZER INC cash provided by (used in) operating activities, discontinued operations for fiscal 2021 was -$343.00M, a 108.88% decline from fiscal 2020.
- PFIZER INC cash provided by (used in) operating activities, discontinued operations for fiscal 2020 was $3.86B, a 30.67% decline from fiscal 2019.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month as first filed | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month as first filed | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-22 | ||||||
| 2023-07-02 | $0.00 10-Q · filed 2023-08-09 | ||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $5.00M derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | |||
| 2022-10-02 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-08-09 | $0.00 10-Q · filed 2022-11-09 | -$16.00M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-07-03 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$5.00M 10-Q · filed 2023-08-09 | -$21.00M derived: sum of 3 quarters · filed 2024-02-22 | -$357.00M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-04-03 | $0.00 10-Q · filed 2022-05-11 | -$16.00M derived: sum of 2 quarters · filed 2024-02-22 | -$352.00M derived: sum of 3 quarters · filed 2024-02-22 | -$335.00M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2021-12-31 | -$16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$352.00M derived: sum of 2 quarters · filed 2024-02-22 | -$335.00M derived: sum of 3 quarters · filed 2024-02-22 | -$343.00M 10-K · filed 2024-02-22 | |||
| 2021-10-03 | -$336.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$319.00M derived: sum of 2 quarters · filed 2022-11-09 | -$327.00M 10-Q · filed 2022-11-09 | $6.00M 10-Q · filed 2021-11-12 | $1.12B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-07-04 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $9.00M 10-Q · filed 2022-08-10 | $1.46B derived: sum of 3 quarters · filed 2023-02-23 | $2.01B derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-04-04 | -$8.00M 10-Q · filed 2022-05-11 | $9.00M 10-Q · filed 2021-05-13 | $1.44B derived: sum of 2 quarters · filed 2023-02-23 | $2.00B derived: sum of 3 quarters · filed 2023-02-23 | $2.88B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2020-12-31 | $1.45B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.00B derived: sum of 2 quarters · filed 2023-02-23 | $2.88B derived: sum of 3 quarters · filed 2023-02-23 | $3.86B 10-K · filed 2023-02-23 | $3.82B 10-K · filed 2021-02-25 | ||
| 2020-09-27 | $554.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.44B derived: sum of 2 quarters · filed 2021-11-12 | $2.41B 10-Q · filed 2021-11-12 | ||||
| 2020-06-28 | $882.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.86B 10-Q · filed 2021-08-12 | |||||
| 2020-03-29 | $978.00M 10-Q · filed 2021-05-13 | ||||||
| 2019-12-31 | $5.57B 10-K · filed 2022-02-24 | $5.58B 10-K · filed 2021-02-25 | |||||
| 2018-12-31 | $6.95B 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |